Tvardi Therapeutics, Inc. (TVRD) — Tangible Net Worth Ratio
Tvardi Therapeutics, Inc. (TVRD) has a Tangible Net Worth Ratio of 97.9% as of March 2026. This metric is calculated by deducting intangible assets ($306.00K) from net assets ($14.51 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Tvardi Therapeutics, Inc. (TVRD) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tvardi Therapeutics, Inc. Tangible Net Worth Ratio (2020–2025)
This chart shows how Tvardi Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 3 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 97.9%, reflecting net assets of $14.51 Million with intangible assets of $306.00K USD. For live market cap and overall valuation, see TVRD stock market capitalisation.
Annual Tangible Net Worth Ratio for Tvardi Therapeutics, Inc. (2020–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Tvardi Therapeutics, Inc. from 2020 to 2025, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial agility of Tvardi Therapeutics, Inc. to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.5% | $20.95 Million | $322.00K | $32.07 Million | ▼ -1.5 pp |
| 2021 | 100.0% | $227.52 Million | $0.00 | $247.06 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $249.00 Million | $0.00 | $271.16 Million | — |